What Happened?
Eden Prairie, AB-based Metavention Appointed Kevin Hykes as Chief Executive Officer
About the Company
Metavention is a venture-backed medical device company founded in 2012 that is developing a novel glucose control therapy for patients with type 2 diabetes. Metabolic Neuromodulation Therapy (MNT) is a simple cardiovascular procedure intended to modulate sympathetic nervous system activity in patients with Type 2 diabetes for the purpose of lowering blood glucose levels. MNT was developed based on published scientific data and extensive animal studies suggesting a link between elevated sympathetic nerve activity in the metabolic system and increased levels of blood glucose. MNT is currently being studied in human clinical trials and represents a potentially important new treatment option for patients with Type 2 Diabetes.
About the Person
Kevin Hykes is Chief Executive Officer at Metavention. Previously, Kevin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile